Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Understand wash sale implications for ERC-20 tokens in 2026 and practical tips to manage deductions and compliance.
16,848 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
As 2026 approaches, two semiconductor giants chart divergent paths: TSMC powers AI chips through its foundry leadersh...
Choosing between VOO and IWO boils down to what kind of U.S. stock exposure you want. This guide breaks down how the ...
A little-known small-cap ETF is turning heads with bold gains in 2026. This guide explains what’s driving the perform...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
In the first half of 2026, Upstart stock fell about 19%, shaking confidence in a fintech darling. This article breaks...
As defense budgets stay elevated and geopolitical tensions linger, investors are targeting the best aerospace and def...
As March 2026 unfolds, investors are parsing the streaming slate for signals on subscriber growth, monetization, and ...
As April 2026 approaches, investors face AI chatter, geopolitical headlines, and macro uncertainty. This guide offers...
A 5% pullback in the Nasdaq in 2026 echoes big past moves and offers clues about which stocks tend to fare best durin...
Century DeAnna Realty capped a five-year growth sprint with a 110% rise in transactions, leveraging culture-driven M&...
The York-based TruAdvantage Team unveils a 5,000-square-foot agent support hub as it pushes through a record 2025 and...